Glenview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$650M |
| 2 |
Zimmer Biomet
ZBH
|
+$283M |
| 3 |
McKesson
MCK
|
+$239M |
| 4 |
DuPont de Nemours
DD
|
+$133M |
| 5 |
Pentair
PNR
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$186M |
| 2 |
Humana
HUM
|
+$173M |
| 3 |
DD
Du Pont De Nemours E I
DD
|
+$144M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$136M |
| 5 |
Cigna
CI
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.07% |
| 2 | Materials | 13.85% |
| 3 | Technology | 10.28% |
| 4 | Communication Services | 9.41% |
| 5 | Consumer Discretionary | 8.44% |
Similar funds
Glenview Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Glenview Capital Management held 61 positions worth $17.2B, up 12% from $15.4B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Glenview Capital Management deployed $1.19B of net new capital in Q3 2017, opening 9 new positions and adding to 21 existing holdings. Its largest new stake was Pentair: 2,637,268 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 43% a quarter earlier, followed by Materials and Technology.
On the sell side, the largest reduction was Lowe's Companies, an estimated $186M trimmed.
- Glenview Capital Management's largest Q3 2017 buy was Pentair: 2,637,268 shares worth $120M.
- Glenview Capital Management added most to Shire pic in Q3 2017, an estimated $650M increase.
- Glenview Capital Management's biggest Q3 2017 reduction was Lowe's Companies, cutting an estimated $186M.
- Glenview Capital Management fully exited Humana in Q3 2017, selling an estimated $173M.
- Glenview Capital Management's ten largest holdings make up 49% of its $17.2B portfolio in Q3 2017.
- Glenview Capital Management opened 9 new positions and closed 5 in Q3 2017.
- Glenview Capital Management's portfolio value rose 12% quarter-over-quarter to $17.2B.
Based on Glenview Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.